Halopropane

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Halopropane
Halopropane.svg
Clinical data
Trade names Tebron
ATC code
  • None
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
Formula C3H3BrF4
Molar mass 194.954 g/mol
3D model (JSmol)

Halopropane (synonym FHD-3, trade name Tebron) is a halocarbon drug which was investigated as an inhalational anesthetic but was never marketed.[1] Its clinical development was terminated due to a high incidence of cardiac arrhythmias in patients, similarly to the cases of teflurane and norflurane.[2][3][4]

See also[edit]

References[edit]

  1. ^ Nigel R. Webster; Helen F. Galley (22 August 2013). Landmark Papers in Anaesthesia. OUP Oxford. pp. 70–. ISBN 978-0-19-163319-5. 
  2. ^ Acta anaesthesiologica Belgica. Acta Medica Belgica. 1974. 
  3. ^ Sanford L. Klein (1993). A glossary of anesthesia and related terminology. Springer-Verlag. ISBN 978-0-387-97831-4. 
  4. ^ Earl J. Catcott; J. F. Smithcors (1973). Progress in canine practice. American Veterinary Publications.